Skip to main content

19th International Conference of the Society on Sarcopenia, Cachexia, & Wasting Disorders (SCWD), Washington, DC

December 10th - 12th, 2026 - Washington, DC

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX

MitoXcel™ Geropeptide PTC-2105 Attenuates Terminal Lean-Mass Decline and Semaglutide-Associated Lean-Mass Loss in Aged Mice

Kevin Slawin, MD, Founder and CEO, Eos SENOLYTIX
Washington, DC
December 10 – 12, 2026